Scholar Rock Holding Corp (SRRK)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track Share on 𝕏

Stock chart

Ticker: SRRK Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2024-02-21	2024-02-16	S Sale	Myles Edward H COO & CFO Officer	4,744 -2.2% 15.74 74,686 USD	4,744 -2.2%	15.74	74,686 USD
2024-02-20	2024-02-16	S Sale	Parlavecchio Caryn CHRO Officer	3,751 -2.3% 15.74 59,053 USD	3,751 -2.3%	15.74	59,053 USD
2024-02-20	2024-02-16	S Sale	Ho Junlin GENERAL COUNSEL Officer	3,489 -1.6% 15.74 54,928 USD	3,489 -1.6%	15.74	54,928 USD
2024-02-20	2024-02-16	S Sale	Qatanani Mo CHIEF SCIENTIFIC OFFICER Officer	2,512 -1.7% 15.74 39,547 USD	2,512 -1.7%	15.74	39,547 USD
2024-02-20	2024-02-16	S Sale	Backstrom Jay T. CHIEF EXECUTIVE OFFICER Executive Director	11,614 -3.2% 15.74 182,842 USD	11,614 -3.2%	15.74	182,842 USD
2024-01-18	2024-01-16	S Sale	Ho Junlin GENERAL COUNSEL Officer	4,186 -2.6% 15.93 66,677 USD	4,186 -2.6%	15.93	66,677 USD
2024-01-18	2024-01-16	S Sale	Qatanani Mo SVP AND HEAD OF RESEARCH Officer	2,002 -2.5% 15.93 31,889 USD	2,002 -2.5%	15.93	31,889 USD
2024-01-18	2024-01-16	S Sale	Parlavecchio Caryn CHRO Officer	2,849 -2.4% 15.93 45,381 USD	2,849 -2.4%	15.93	45,381 USD
2024-01-18	2024-01-16	S Sale	Myles Edward H COO & CFO Officer	6,634 -3.9% 15.93 105,670 USD	6,634 -3.9%	15.93	105,670 USD
2023-12-29	2023-12-29	PS Planned sale	Myles Edward H COO & CFO Officer	300 -0.2% 19.51 5,853 USD	300 -0.2%	19.51	5,853 USD
2023-12-29	2023-12-29	PS Planned sale	Myles Edward H COO & CFO Officer	12,159 -6.7% 18.82 228,780 USD	12,159 -6.7%	18.82	228,780 USD
2023-12-15	2023-12-14	S Sale	Qatanani Mo SVP AND HEAD OF RESEARCH Officer	24,662 -23.4% 18.18 448,444 USD	24,662 -23.4%	18.18	448,444 USD
2023-12-08	2023-12-07	PS Planned sale	Myles Edward H COO & CFO Officer	24,914 -12.9% 17.53 436,820 USD	24,914 -12.9%	17.53	436,820 USD
2023-11-03	2023-11-02	PS Planned sale	Myles Edward H COO & CFO Officer	35,007 -17.2% 12.51 438,039 USD	35,007 -17.2%	12.51	438,039 USD
2023-10-18	2023-10-16	B Purchase	Samsara BioCapital GP, LLC Large shareholder	2,189,781 +47.6% 6.85 15,000,000 USD	2,189,781 +47.6%	6.85	15,000,000 USD
2023-10-18	2023-10-16	B Purchase	AKKARAJU SRINIVAS Non-Executive Director Large shareholder	2,189,781 +47.6% 6.85 15,000,000 USD	2,189,781 +47.6%	6.85	15,000,000 USD
2023-10-16	2023-10-12	B Purchase	Invus Public Equities, L.P. Large shareholder	10,150 +0.1% 8.55 86,736 USD	10,150 +0.1%	8.55	86,736 USD
2023-10-16	2023-10-12	B Purchase	Invus Public Equities, L.P. Large shareholder	2,189,781 +24.2% 6.85 15,000,000 USD	2,189,781 +24.2%	6.85	15,000,000 USD
2023-09-20	2023-09-18	S Sale	Qatanani Mo SVP AND HEAD OF RESEARCH Officer	1,945 -2.0% 6.34 12,331 USD	1,945 -2.0%	6.34	12,331 USD
2023-08-18	2023-08-16	S Sale	Parlavecchio Caryn CHRO Officer	1,353 -1.1% 6.83 9,241 USD	1,353 -1.1%	6.83	9,241 USD
2023-05-02	2023-04-28	B Purchase	Invus Public Equities, L.P. Large shareholder	31,557 +0.3% 6.43 202,845 USD	31,557 +0.3%	6.43	202,845 USD
2023-01-11	2023-01-09	S Sale	Invus Public Equities, L.P. Large shareholder	1,094 -0.0% 9.48 10,373 USD	1,094 -0.0%	9.48	10,373 USD
2023-01-09	2023-01-05	B Purchase	Invus Public Equities, L.P. Large shareholder	48,774 +0.5% 9.33 455,091 USD	48,774 +0.5%	9.33	455,091 USD
2022-10-27	2022-10-25	B Purchase	Invus Public Equities, L.P. Large shareholder	130,265 +1.5% 8.04 1,047,383 USD	130,265 +1.5%	8.04	1,047,383 USD
2022-10-07	2022-10-04	B Purchase	Invus Public Equities, L.P. Large shareholder	66,000 +0.8% 7.89 520,760 USD	66,000 +0.8%	7.89	520,760 USD
2022-10-07	2022-10-03	B Purchase	Invus Public Equities, L.P. Large shareholder	33,971 +0.4% 7.03 238,789 USD	33,971 +0.4%	7.03	238,789 USD
2022-06-24	2022-06-22	B Purchase	Nashat Amir Non-Executive Director	66,142 +47.0% 4.90 324,096 USD	66,142 +47.0%	4.90	324,096 USD
2022-06-24	2022-06-22	B Purchase	Nashat Amir Non-Executive Director	1,131,850 +47.0% 4.90 5,546,065 USD	1,131,850 +47.0%	4.90	5,546,065 USD
2021-11-15	2021-11-15	PS Planned sale	Myles Edward H Chief Financial Officer Officer	4,879 -16.8% 35.05 171,006 USD	4,879 -16.8%	35.05	171,006 USD
2021-11-15	2021-11-12	PS Planned sale	Myles Edward H Chief Financial Officer Officer	49,848 -67.4% 35.12 1,750,437 USD	49,848 -67.4%	35.12	1,750,437 USD
2021-11-15	2021-11-11	PS Planned sale	Myles Edward H Chief Financial Officer Officer	23,574 -49.4% 35.20 829,857 USD	23,574 -49.4%	35.20	829,857 USD
2021-10-05	2021-10-01	PS Planned sale	FLIER JEFFREY S. Non-Executive Director	6,000 -21.2% 30.89 185,329 USD	6,000 -21.2%	30.89	185,329 USD
2021-03-17	2021-03-15	PS Planned sale	Gilman Michael Non-Executive Director	4,696 -11.1% 65.59 307,998 USD	4,696 -11.1%	65.59	307,998 USD
2021-02-11	2021-02-08	PS Planned sale	Gilman Michael Non-Executive Director	1,804 -4.1% 65.06 117,361 USD	1,804 -4.1%	65.06	117,361 USD
2021-01-28	2021-01-27	PS Planned sale	Carven Gregory John Head of Research Officer	1,561 -5.5% 57.79 90,212 USD	1,561 -5.5%	57.79	90,212 USD
2021-01-28	2021-01-27	PS Planned sale	Carven Gregory John Head of Research Officer	12,139 -29.9% 56.72 688,511 USD	12,139 -29.9%	56.72	688,511 USD
2021-01-28	2021-01-27	PS Planned sale	Carven Gregory John Head of Research Officer	5,400 -11.7% 55.87 301,680 USD	5,400 -11.7%	55.87	301,680 USD
2021-01-28	2021-01-26	PS Planned sale	Gilman Michael Non-Executive Director	1,518 -3.3% 59.90 90,928 USD	1,518 -3.3%	59.90	90,928 USD
2021-01-28	2021-01-26	PS Planned sale	Gilman Michael Non-Executive Director	1,500 -3.2% 59.02 88,533 USD	1,500 -3.2%	59.02	88,533 USD
2021-01-28	2021-01-26	PS Planned sale	Gilman Michael Non-Executive Director	483 -1.0% 57.99 28,008 USD	483 -1.0%	57.99	28,008 USD
2021-01-28	2021-01-26	PS Planned sale	Carven Gregory John Head of Research Officer	1,064 -2.3% 61.52 65,453 USD	1,064 -2.3%	61.52	65,453 USD
2021-01-28	2021-01-26	PS Planned sale	Carven Gregory John Head of Research Officer	8,417 -15.2% 60.65 510,494 USD	8,417 -15.2%	60.65	510,494 USD
2021-01-28	2021-01-26	PS Planned sale	Carven Gregory John Head of Research Officer	9,249 -14.3% 59.69 552,098 USD	9,249 -14.3%	59.69	552,098 USD
2021-01-28	2021-01-26	PS Planned sale	Carven Gregory John Head of Research Officer	13,368 -17.1% 58.79 785,969 USD	13,368 -17.1%	58.79	785,969 USD
2021-01-28	2021-01-26	PS Planned sale	Carven Gregory John Head of Research Officer	4,676 -5.7% 57.91 270,807 USD	4,676 -5.7%	57.91	270,807 USD
2018-05-31	2018-05-29	B Purchase	Polaris Venture Management Co. VI, L.L.C. Large shareholder	7,887 +5.3% 14.00 110,418 USD	7,887 +5.3%	14.00	110,418 USD
2018-05-31	2018-05-29	B Purchase	Polaris Venture Management Co. VI, L.L.C. Large shareholder	134,970 +5.3% 14.00 1,889,580 USD	134,970 +5.3%	14.00	1,889,580 USD
2018-05-31	2018-05-29	B Purchase	Nashat Amir Non-Executive Director Large shareholder	7,887 +5.3% 14.00 110,418 USD	7,887 +5.3%	14.00	110,418 USD
2018-05-31	2018-05-29	B Purchase	Nashat Amir Non-Executive Director Large shareholder	134,970 +5.3% 14.00 1,889,580 USD	134,970 +5.3%	14.00	1,889,580 USD
2018-05-31	2018-05-29	B Purchase	Artal International S.C.A. Large shareholder	450,000 +inf% 14.00 6,300,000 USD	450,000 +inf%	14.00	6,300,000 USD
2018-05-31	2018-05-29	B Purchase	SPRINGER TIMOTHY A Non-Executive Director Large shareholder	71,428 +2.2% 14.00 999,992 USD	71,428 +2.2%	14.00	999,992 USD